A large retrospective study of the UNOS database advances that elevated troponin I in selected cardiac donors is NOT associated with various adverse events. The conclusion is likely to stimulate heated discussions.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Heart Failure
June 25, 2016
May 21, 2016
This review provides an excellent summary of patient outcomes following LVAD explantation. The authors review 11 studies comprosing of 213 patients and conclude that excellent 10 year survival outcomes can be maintained after LVAD explantation in carefully selected patients.
April 28, 2016
Stephen Westaby reflects on his extraordinary career in cardiac surgery in an interview with Leanne Harling, which was filmed at the 2015 EACTS Annual Meeting in Amsterdam, the Netherlands.
April 23, 2016
An editorial discussion of the impressive 10-year benefits of CABG for ischemic cardiomyopathy as found in the STICH trial.
March 31, 2016
A commentary and follow-up comment on last year's ERICCA and RIPHeart- related publications in the NEJM.
March 13, 2016
This Belgian study prospectively analyzed the predictors of long-term mortality in a group of 107 consecutive CABG patients with an LV EF < 35%. All patients underwent preoperative Cardiac MR to assess both LV and RV EF.
February 2, 2016
This randomized trial (NEAT-HFpEF) of 110 subjects (59 placebos) disproves, by clinical and biological markers, the utility of nitrates for exercise tolerance. This is a subset of cardiac failure patients we are likely to encounter in general cardiothoracic surgical practice.
January 9, 2016
The authors performed a randomized control study of 178 patients with heart failure and systolic dyssynchrony who were accepted for CABG, randomizing the participants into two groups: CABG alone (n=87) and CABG + concomitant epicardial CRT (n=91). CRT was activated postoperatively.
November 5, 2015
This is a very intersting case review in which the authors describe a successful heart transplant from a 37 year old donor on VV ECMO to a 62 year old female recipeint. The authors postulate that this successful outcome may expand the available donor pool for heart transplantation.
September 4, 2015
Changes in risk profile and outcomes over 40 years were assessed from the Stanford experience with heart transplant in children. Age at transplant decreased in the most recent time period from about 10 to 5.6 years. The use of mechnical support as bridge increased dramatically over the time of the study. Long-term survival increased dramatically,